Clinical Trial Update: Sitagliptin Treatment in Patients With Type 2 DM After Kidney Transplant [NA]

View source ↗

Summary

A completed clinical trial assessed Sitagliptin for Type 2 Diabetes in kidney transplant recipients. The report notes completion but does not provide results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Sitagliptin (sitagliptin)

Snippet

Sponsor: University of Oklahoma | Conditions: Kidney Transplant, Type 2 Diabetes | NA | Status: COMPLETED